Pooled estimates | Hospital-specific estimates | ||||
---|---|---|---|---|---|
Indicator | n | % | Cluster adjusted 95% CI | Median %* | Range %† |
1. NAR used (n=1249) | 711 | 57 | 36 to 78 | 75 | 0–100 |
2. Symptoms and signs | |||||
Symptom score (maximum 3)‡ | 0 | 0–3§ | – | 0 | 0–3 |
Sign score (maximum 8)¶ | 6 | 4–7§ | – | 5.8 | 0–8 |
3. Maternal HIV status | |||||
Status documented | 674 | 54 | 42 to 66 | 64 | 0–93 |
Positive | 83/674 | 12 | 8 to 20 | 9.1 | 0–56 |
ARV for PMTCT prescribed for baby | 54/82 | 66 | 47 to 81 | – | – |
4. Antibiotic prescription | |||||
Benzylpenicillin dosage (n=778) | |||||
Appropriate | 649 | 83 | 66 to 93 | 93 | 0–100 |
Overdose | 90 | 12 | 3.4 to 33 | 4.2 | 0–100** |
Gentamicin dosage (n=761) | |||||
Appropriate | 473 | 62 | 51 to 73 | 67 | 7.7–91 |
Overdose | 141 | 19 | 13 to 25 | 20 | 1.9–67 |
5. Supportive care | |||||
Vitamin K prescribed (n=1213) | 843 | 70 | 57 to 80 | 73 | 10–100 |
Appropriate dose of intravenous fluids (n=473)†† | 290 | 61 | 52 to 71 | 57 | 0–90 |
Appropriate amount of feeds (n=109)†† | 55 | 51 | 26 to 75 | 14 | 0–100 |
6. Medical review and monitoring | |||||
Reviewed >24 h after admission (n=922) | 20 | 2.2 | 1 to 4.8 | 0.8 | 0–21 |
Vital signs charted (n=1248) | 970 | 78 | 68 to 87 | 85 | 8.3–100 |
Weight charted (n=1249) | 510 | 41 | 25 to 56 | 39 | 0–100 |
Fluids monitored (n=559)‡‡ | 193 | 35 | 19 to 55 | 19 | 0–100 |
*Median of individual hospital median scores.
†Range of individual hospital median scores.
‡Difficulty feeding, convulsions and fits.
§IQR.
¶Temperature, bulging fontanelle, suck reflex/ability to feed, muscle tone, respiratory rate, severe indrawing, grunting and cyanosis.
**In the facility with 100% overdose, all penicillin doses were double the recommended.
††Treatment sheet with either intravenous fluids or supplementary feeds only for the first 24 h of life.
‡‡Five hundred and fifty-nine neonates had a fluid prescription on any day of life (473 of these on the first day).
ARV, antiretroviral; NAR, newborn admission record; PMTCT, preventing mother-to-child transmission.